substantia nigra pars compacta
Coordination Mechanism in Dopamine Neurons of the Substantia Nigra Pars Compacta and Norepinephrine Neurons of the Locus Coeruleus
26
Differentiation and molecular heterogeneity of inhibitory and excitatory neurons associated with midbrain dopaminergic nuclei
14
Anatomy and relevance in pharmacotherapy of diseases related to Basal Ganglia
19
Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease
6
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
16
Direct detection of alpha synuclein oligomers in vivo
10
Tyrosine hydroxylase and Lewy body molecules immunoreactivity in the SNC neurons of an AS/AGU mutantrat
6
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
7
Evaluation of Parkinson Disease and Alzheimer Disease with the Use of Neuromelanin MR Imaging and 123I Metaiodobenzylguanidine Scintigraphy
6
Evaluation of the Substantia Nigra in Patients with Parkinsonian Syndrome Accomplished Using Multishot Diffusion Weighted MR Imaging
7
The neuronal structure of the substantia nigra in the guinea pig: Nissl and Golgi study
7
MRI Characteristics of Globus Pallidus Infarcts in Isolated Methylmalonic Acidemia
8
MODERN STEREOLOGICAL EVALUATION IN THE AGING HUMAN SUBSTANTIA NIGRA
8
Substantia nigra hyperechogenicity in Polish patients with Parkinson’s disease
5
Transcranial Sonography of the Substantia Nigra: Digital Image Analysis
6
Proteome analysis of human substantia nigra in Parkinson's disease
14
Recent Advances on the Management of Parkinson’s Disease: A Review
12
Human substantia nigra neurons encode unexpected financial rewards
6
Insight into hypoglycemia in pediatric type 1 diabetes mellitus
7
Human substantia nigra neurons encode unexpected financial rewards
7